Holen Sie sich die Stockscreener-App
23.43
0.66%
0.205
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CCL?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$23.23
Offen:
$23.62
24-Stunden-Volumen:
10.27M
Relative Volume:
0.47
Marktkapitalisierung:
$32.05B
Einnahmen:
$26.98B
Nettoeinkommen (Verlust:
$3.10B
KGV:
10.42
EPS:
2.2492
Netto-Cashflow:
$2.98B
1W Leistung:
-8.62%
1M Leistung:
-15.95%
6M Leistung:
-19.76%
1J Leistung:
-24.96%
1-Tages-Spanne:
$23.35
$23.92
1-Wochen-Bereich:
$23.07
$25.60
52-Wochen-Spanne:
$23.07
$34.03
Colgate Palmolive Co Stock (CCL) Company Profile
Firmenname
Colgate Palmolive Co
Sektor
Telefon
(305) 599-2600
Adresse
3655 NW 87TH AVE, MIAMI, FL
Compare CCL vs PG, UL, CL, EL, KVUE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CCL
Colgate Palmolive Co
|
23.40 | 34.75B | 26.98B | 3.10B | 2.98B | 2.2492 |
PG
Procter Gamble Co
|
147.95 | 332.32B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
64.69 | 136.52B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
90.71 | 71.51B | 20.80B | 2.22B | 3.77B | 2.5772 |
EL
Estee Lauder Cos Inc
|
101.34 | 34.79B | 14.85B | -248.00M | 1.29B | -0.6966 |
KVUE
Kenvue Inc
|
19.07 | 36.36B | 15.29B | 1.62B | 1.82B | 0.8433 |
Colgate Palmolive Co Stock (CCL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-30 | Hochstufung | HSBC Securities | Hold → Buy |
| 2026-03-19 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-18 | Eingeleitet | Wells Fargo | Overweight |
| 2025-07-22 | Eingeleitet | TD Cowen | Buy |
| 2025-07-16 | Bestätigt | Citigroup | Buy |
| 2025-05-16 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2025-04-25 | Eingeleitet | Northcoast | Neutral |
| 2025-04-10 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-03-27 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2025-02-05 | Eingeleitet | Loop Capital | Hold |
| 2024-12-23 | Bestätigt | Barclays | Overweight |
| 2024-12-23 | Bestätigt | Citigroup | Buy |
| 2024-12-23 | Bestätigt | Stifel | Buy |
| 2024-11-26 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-03-26 | Eingeleitet | Mizuho | Buy |
| 2024-03-13 | Eingeleitet | Goldman | Buy |
| 2024-01-05 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-11-21 | Fortgesetzt | Citigroup | Buy |
| 2023-10-02 | Fortgesetzt | William Blair | Outperform |
| 2023-09-19 | Hochstufung | Truist | Sell → Hold |
| 2023-09-14 | Hochstufung | Redburn Atlantic | Neutral → Overweight |
| 2023-07-18 | Hochstufung | Argus | Hold → Buy |
| 2023-06-30 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-12 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-06-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-05-25 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-04-28 | Eingeleitet | JP Morgan | Neutral |
| 2023-03-29 | Hochstufung | Susquehanna | Neutral → Positive |
| 2023-03-28 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-12-06 | Fortgesetzt | JP Morgan | Neutral |
| 2022-06-29 | Eingeleitet | Barclays | Overweight |
| 2022-06-29 | Bestätigt | Morgan Stanley | Underweight |
| 2022-06-09 | Eingeleitet | Susquehanna | Neutral |
| 2022-03-30 | Eingeleitet | Wells Fargo | Underweight |
| 2022-03-25 | Herabstufung | Argus | Buy → Hold |
| 2022-01-05 | Fortgesetzt | Jefferies | Hold |
| 2021-10-25 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-10-21 | Hochstufung | Berenberg | Sell → Hold |
| 2021-08-06 | Bestätigt | Citigroup | Buy |
| 2021-06-16 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2021-04-09 | Hochstufung | Argus | Hold → Buy |
| 2021-04-09 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-04-01 | Eingeleitet | Citigroup | Buy |
| 2021-03-18 | Hochstufung | UBS | Neutral → Buy |
| 2021-03-02 | Hochstufung | Macquarie | Neutral → Outperform |
| 2021-02-12 | Herabstufung | Berenberg | Hold → Sell |
| 2021-01-26 | Fortgesetzt | HSBC Securities | Reduce |
| 2020-09-25 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-07-21 | Herabstufung | HSBC Securities | Buy → Hold |
| 2020-07-14 | Herabstufung | Macquarie | Outperform → Neutral |
| 2020-07-14 | Herabstufung | SunTrust | Hold → Sell |
| 2020-06-03 | Fortgesetzt | Morgan Stanley | Underweight |
| 2020-05-21 | Eingeleitet | Credit Suisse | Neutral |
| 2020-05-11 | Hochstufung | HSBC Securities | Hold → Buy |
| 2020-03-23 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2020-03-10 | Herabstufung | Goldman | Buy → Neutral |
| 2019-12-23 | Hochstufung | Standpoint Research | Hold → Buy |
| 2019-11-21 | Herabstufung | SunTrust | Buy → Hold |
| 2019-10-07 | Herabstufung | HSBC Securities | Buy → Hold |
| 2019-09-27 | Herabstufung | Berenberg | Hold → Sell |
| 2019-09-27 | Herabstufung | UBS | Buy → Neutral |
| 2019-07-01 | Herabstufung | Berenberg | Buy → Hold |
| 2019-06-27 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-06-21 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-06-20 | Herabstufung | Nomura | Buy → Neutral |
| 2019-06-20 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-04-15 | Herabstufung | Buckingham Research | Buy → Neutral |
Alle ansehen
Colgate Palmolive Co Aktie (CCL) Neueste Nachrichten
Colgate-Palmolive India Taps Kenvue's Manish Anandani as Next CEO - finance.biggo.com
UBS reiterates Colgate-Palmolive stock Buy rating at $109 target By Investing.com - Investing.com Canada
Colgate-Palmolive Taps Kenvue Executive Anandani As India CEO - outlookbusiness.com
Impax Asset Management Group plc Has $11.95 Million Stock Holdings in Colgate-Palmolive Company $CL - MarketBeat
Manish Anandani returns to Colgate-Palmolive as India CEO, succeeding Prabha NarasimhanPeople Matters - People Matters - HR News
Colgate-Palmolive elevates Prabha Narasimhan to EVPMarketing, Asia-Pacific and announces Manish Anandani as new MD & CEO for India - Business Standard
Vise Technologies Inc. Has $6.84 Million Stock Position in Colgate-Palmolive Company $CL - MarketBeat
Business News - LatestLY
Colgate-Palmolive appoints Manish Anandani as new India CEO - The Times of India
Colgate Palmolive India Appoints Kenvue Executive As MD And CEO - ESM Magazine
Bank of New York Mellon Corp Boosts Stock Holdings in Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive India Names Manish Anandani as MD & CEO - Whalesbook
B. Metzler seel. Sohn & Co. AG Has $14.48 Million Position in Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive India Names Manish Anandani as New MD and CEO - News Mobile
Prabha Narasimhan moves to Colgate-Palmolive Asia-Pacific as Manish Anandani takes over as India MD and CEO - Campaign India
Colgate India names Manish Anandani CEO as Prabha Narasimhan moves to APAC - Indian Television Dot Com
Colgate India Names Manish Anandani As New CEO - BW Businessworld
Palmolive elevates Prabha Narasimhan to EVPMarketing - MediaBrief
Prabha Narasimhan moves to APAC role as Colgate-Palmolive names Manish Anandani MD & CEO - IMPACT Magazine
Prabha Narasimhan elevated to global role, Manish Anandani to lead India operations at Colgate-Palmolive - BusinessLine
Colgate-Palmolive India appoints Manish Anandani as MD & CEO - IMPACT Magazine
Colgate India names Manish Anandani as managing director - The Economic Times
Colgate-Palmolive India appoints Manish Anandani as MD and CEO - scanx.trade
Colgate-Palmolive India Appoints New MD & CEO Manish Anandani - Whalesbook
Colgate-Palmolive Company $CL Shares Purchased by Madison Asset Management LLC - MarketBeat
Colgate-Palmolive Company $CL Stock Position Lessened by Tocqueville Asset Management L.P. - MarketBeat
Flossbach Von Storch SE Sells 325,419 Shares of Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive Company $CL Shares Sold by Great Lakes Advisors LLC - MarketBeat
Diversify Advisory Services LLC Invests $1.10 Million in Colgate-Palmolive Company $CL - MarketBeat
Abacus FCF Advisors LLC Has $5.46 Million Stock Holdings in Colgate-Palmolive Company $CL - MarketBeat
DIAMOND HILL LARGE CAP CONCENTRATED ETF's Colgate-Palmolive Co(CL) Holding History - GuruFocus
Colgate-Palmolive Stock Slips Below 50-Day SMA: Time to Be Cautious? - Yahoo Finance
CL DCF Analysis: Intrinsic Value $44 vs Price $91 - GuruFocus
Wealthfront Advisers LLC Grows Stock Holdings in Colgate-Palmolive Company $CL - MarketBeat
Danske Bank A S Reduces Stock Holdings in Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive Shares Slip 2% as Market Weighs Growth Plan - Whalesbook
Danica Pension Livsforsikringsaktieselskab Sells 100,763 Shares of Colgate-Palmolive Company $CL - MarketBeat
Colgate Partners With BTS’ j-hope For New Optic White Range Campaign - Branding in Asia
Zacks Investment ResearchGlobes - Globes - Israel Business News
Colgate PerioGard Sets a New Gold Standard: Becomes India's First Gum Care Regimen to Earn the ISP Seal of Acceptance - Big News Network.com
Nomura Maintains 'Buy' on Colgate-Palmolive India, Target at Rs 2,550 - Whalesbook
Colgate PerioGard Sets a New Gold Standard: Becomes India’s First Gum Care Regimen to Earn the ISP Seal of Acceptance - ThePrint
Colgate Falls 3% As Brokerages Flag Margin Risks - BW Businessworld
Colgate India steps up premiumisation as oral-care growth finds new bite - Indian Television Dot Com
Input Inflation Returns, Colgate-Palmolive May Raise Prices - The Economic Times
Colgate Taps Bombay Shaving Company to Drive Palmolive’s D2C Growth - Indian Retailer
Why Colgate-Palmolive Remains an Overlooked Dividend King - Yahoo Finance
Colgate-Palmolive May Raise Prices Again As Input Costs Rise - outlookbusiness.com
Colgate PerioGard becomes India's first gum care regimen to earn ISP Seal of Acceptance - scanx.trade
26,725 Shares in Colgate-Palmolive Company $CL Purchased by Trust Co. of Vermont - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Has $185.71 Million Position in Colgate-Palmolive Company $CL - MarketBeat
Finanzdaten der Colgate Palmolive Co-Aktie (CCL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):